Orthopedics Executive Don Urbanowicz Joins Flex Biomedical’s Board of Directors
February 9, 2011, Madison, WI—Flex Biomedical, Inc., a privately-held biomedical company focused on developing novel treatments for orthopedic diseases today announced that Don Urbanowicz, a highly experienced orthopedics executive, has joined the board of directors.
Download Press Release [PDF]

Flex Biomedical Raises $866,000 Financing Round
January 27, 2011, Madison, WI—Officials at Flex Biomedical, Inc., a privately-held biomedical company focused on developing novel treatments for orthopedic diseases, today announced that they have closed an $866,000 financing round.
Download Press Release [PDF]

Flex Biomedical Awarded over $244,000 From Qualified Therapeutic Discovery Project Program
November 2, 2010, Madison, WI—Flex Biomedical, Inc., a privately-held biomedical company focused on developing novel treatments for orthopedic diseases today announces that it was awarded $244,479 from the IRS’ Qualified Therapeutic Discovery Project grant program.
Download Press Release [PDF]

Flex Biomedical to Present at Premiere Orthopedic Conference
October 21, 2010, Madison, WI—Flex Biomedical, Inc., a privately-held biomedical company focused on developing novel treatments for orthopedic diseases today announces that company CEO, Sal Braico, was selected to present at the prestigious Musculoskeletal New Ventures Conference on October 26, 2010, in Memphis.
Download Press Release [PDF]

Flex Biomedical to Present at BioPharm America 2010 and
MedVestors Conferences

September 14, 2010, Madison, WI - Flex Biomedical, Inc., a privately-held biomedical company focused on developing novel treatments for orthopedic diseases today announced that the company was selected to present at two prestigious conferences. CEO Sal Braico will present at the BioPharm America 2010 conference on Thursday, September 16, 2010 at 4:00 pm ET. BioPharm America 2010 will be held at the Boston Marriott Copley Place Hotel.
Download Press Release [PDF]

Flex Biomedical Awarded SBIR Grant for Novel Osteoarthritis Treatment
August 19, 2008 Brookline, MA - Flex Biomedical, Inc. announces today that it was awarded a Small Business Innovation Research (SBIR) Phase 1 grant for $175,000 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH).
Download Press Release [PDF]

Flex Biomedical Raises Nearly $1 Million and Moves to WI
August 12, 2009 Madison, WI - Flex Biomedical, Inc., a privately-held orthopedics company focused on developing novel treatments and diagnostics for orthopedic diseases today announced it has raised $985,000 including a $150,000 Technology Venture Fund Loan from the state of Wisconsin. The company is moving its operations from Boston, MA to Madison, Wisconsin.
Download Press Release [PDF]

Osteoarthritis patient population will double by 2020 due to the overweight and aging population.